Enrico Massignani

Enrico Massignani

Auto-generated profile, based on publicly available information

Enrico Massignani

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan 20139, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Cancer Cell
Verified
Journal Article
Closed access
JFJia Yi Fong
Jia Yi Fong
LPLuca Pignata
Luca Pignata
PGPierre-Alexis Goy
Pierre-Alexis Goy
KKKimihito Cojin Kawabata
Kimihito Cojin Kawabata
SLStanley Lee
Stanley Lee
Ernesto GuccioneErnesto Guccione
Ernesto Guccione

2 April 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
DMDaniele Musiani
Daniele Musiani
JBJabez Bok
Jabez Bok
EMEnrico Massignani
Enrico Massignani
LWLiling Wu
Liling Wu
TTTommaso Tabaglio
Tommaso Tabaglio
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
Proteomics identifies target sites and substrates of the arginine methyltransferase PRMT5.

1 January 2020 in Cell Reports
Verified
Journal Article
Open access
DMDaniele Musiani
Daniele Musiani
RGRoberto Giambruno
Roberto Giambruno
EMEnrico Massignani
Enrico Massignani
MIMarica Rosaria Ippolito
Marica Rosaria Ippolito
MMMarianna Maniaci
Marianna Maniaci
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
Protein arginine methyltransferase 1 (PRMT1) is overexpressed in various human cancers and linked to poor response to chemotherapy. Various PRMT1 inhibitors are currently under development; yet, we do not fully understand the mechanisms underpinning PRMT1 involvement in tumorigenesis and chemoresistance. Using mass spectrometry-based proteomics, we identified PRMT1 as regulator of arginine methylation in ovarian cancer cells treated with cisplatin. We showed that DNA-dependent protein kinase (DNA-PK) binds to and phosphorylates PRMT1 in response to cisplatin, inducing its chromatin recruitment and redirecting its enzymatic activity toward Arg3 of histone H4 (H4R3). On chromatin, the DNA-PK/PRMT1 axis induces senescence-associated secretory phenotype through H4R3me2a deposition at pro-inflammatory gene promoters. Finally, PRMT1 inhibition reduces the clonogenic growth of cancer cells exposed to low doses of cisplatin, sensitizing them to apoptosis. While unravelling the role of PRMT1 in response to genotoxic agents, our findings indicate the possibility of targeting PRMT1 to overcome chemoresistance in cancer.

28 November 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
VSValeria Spadotto
Valeria Spadotto
RGRoberto Giambruno
Roberto Giambruno
EMEnrico Massignani
Enrico Massignani
MMMarija Mihailovich
Marija Mihailovich
MMMarianna Maniaci
Marianna Maniaci
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
MicroRNA (miRNA) biogenesis is a tightly controlled multi-step process operated in the nucleus by the activity of the Microprocessor and its associated proteins. Through high resolution mass spectrometry (MS)- proteomics we discovered that this complex is extensively methylated, with 84 methylated sites associated to 19 out of its 24 subunits. The majority of the modifications occurs on arginine (R) residues (61), leading to 81 methylation events, while 30 lysine (K)-methylation events occurs on 23 sites of the complex. Interestingly, both depletion and pharmacological inhibition of the Type-I Protein Arginine Methyltransferases (PRMTs) lead to a widespread change in the methylation state of the complex and induce global decrease of miRNA expression, as a consequence of the impairment of the pri-to-pre-miRNA processing step. In particular, we show that the reduced methylation of the Microprocessor subunit ILF3 is linked to its diminished binding to the pri-miRNAs miR-15a/16, miR-17–92, miR-301a and miR-331. Our study uncovers a previously uncharacterized role of R-methylation in the regulation of miRNA biogenesis in mammalian cells.

18 January 2019 in Proteomics
Verified
Journal Article
Open access
PDF file
EMEnrico Massignani
Enrico Massignani
ACAlessandro Cuomo
Alessandro Cuomo
DMDaniele Musiani
Daniele Musiani
SJSriGanesh Jammula
SriGanesh Jammula
GPGiulio Pavesi
Giulio Pavesi
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
Heavy methyl Stable Isotope Labeling with Amino acids in Cell culture (hmSILAC) is a metabolic labeling strategy employed in proteomics to increase the confidence of global identification of methylated peptides by MS. However, to this day, the automatic and robust identification of heavy and light peak doublets from MS‐raw data of hmSILAC experiments is a challenging task, for which the choice of computational methods is very limited. Here, hmSEEKER, a software designed to work downstream of a MaxQuant analysis for in‐depth search of MS peak pairs that correspond to light and heavy methyl‐peptide within MaxQuant‐generated tables is described with good sensitivity and specificity. The software is written in Perl, and its code and user manual are freely available at Bitbucket (https://bit.ly/2scCT9u).

23 September 2020 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
DMDaniele Musiani
Daniele Musiani
EMEnrico Massignani
Enrico Massignani
ACAlessandro Cuomo
Alessandro Cuomo
AYAvinash Yadav
Avinash Yadav
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
The absence of efficient mass spectrometry-based approaches for the large-scale analysis of protein arginine methylation has hindered the understanding of its biological role, beyond the transcriptional regulation occurring through histone modification. In the last decade, however, several technological advances of both the biochemical methods for methylated polypeptide enrichment and the computational pipelines for MS data analysis have considerably boosted this research field, generating novel insights about the extent and role of this post-translational modification.Here, we offer an overview of state-of-the-art approaches for the high-confidence identification and accurate quantification of protein arginine methylation by high-resolution mass spectrometry methods, which comprise the development of both biochemical and bioinformatics methods. The further optimization and systematic application of these analytical solutions will lead to ground-breaking discoveries on the role of protein methylation in biological processes.